BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 667888)

  • 1. An approach to mineralocorticoid hormone hypertension.
    Biglieri EG
    Cardiovasc Clin; 1978; 9(1):91-7. PubMed ID: 667888
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenal mineralocorticoids causing hypertension.
    Biglieri EG; Stockigt JR; Schambelan M
    Am J Med; 1972 May; 52(5):623-32. PubMed ID: 4556934
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypermineralocorticoidism and hypertension].
    Wolff HP; Abdelhamid S
    Klin Wochenschr; 1971 Mar; 49(6):293-306. PubMed ID: 4932028
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucocorticoid hypertension.
    Pletka PG; Hickler RB
    Cardiovasc Clin; 1978; 9(1):99-111. PubMed ID: 208771
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endocrine hypertension].
    Jahnecke J
    Munch Med Wochenschr; 1970 Nov; 112(47):2123-9. PubMed ID: 4320844
    [No Abstract]   [Full Text] [Related]  

  • 6. Mineralocorticoid hypertension due to hyperaldosteronism and hyperdeoxycorticosteronism.
    Biglieri EG; Kater CE; Arteaga EA
    J Hypertens Suppl; 1986 Dec; 4(5):S61-5. PubMed ID: 3553487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arterial hypertension and mineralocorticoids].
    Molinatti GM; Strumia E
    Folia Endocrinol; 1973 Feb; 26(1):21-48. PubMed ID: 4349746
    [No Abstract]   [Full Text] [Related]  

  • 8. Potassium metabolism and hypertension.
    Uribarri J; Carroll HJ
    J Clin Hypertens; 1985 Dec; 1(4):283-94. PubMed ID: 3014078
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypermineralocorticoid-induced hypertension.
    Biglieri EG
    Med Times; 1969 Oct; 97(10):188-91. PubMed ID: 4310352
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mineralocorticoid syndromes and hypertension].
    Waldhäusl W
    Fortschr Med; 1976 Aug; 94(24):1253-60. PubMed ID: 964885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of adrenal mineralocorticoids in hypertension.
    Tuck M
    Geriatrics; 1978 Jan; 33(1):77-83. PubMed ID: 620928
    [No Abstract]   [Full Text] [Related]  

  • 12. Mineralocorticoid hormones.
    Stockigt JR
    Adv Steroid Biochem Pharmacol; 1976; 5():161-238, 334-5. PubMed ID: 180781
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endocrine hypertension].
    Lehnert H; Scholz T; Schäfer M; Klose S
    Dtsch Med Wochenschr; 2007 Feb; 132(5):207-17; quiz 219-20. PubMed ID: 17252364
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
    Biglieri EG; Kater CE; Arteaga EE
    J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare causes of adrenocortical hypertension.
    Biglieri EG
    Cardiology; 1985; 72 Suppl 1():70-5. PubMed ID: 3902233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
    Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis of hypertension in endocrine disorders. I].
    Fischer V
    Praxis; 1967 Oct; 56(42):1418-25 contd. PubMed ID: 5633168
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical aspects of endocrine hypertension.
    Bravo EL
    Med Clin North Am; 1987 Sep; 71(5):907-20. PubMed ID: 3306210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine causes of hypertension.
    Batsakis JG
    J Ky Med Assoc; 1973 Mar; 71(3):159-68 passim. PubMed ID: 4348559
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenal causes of hypertension.
    Kaplan NN
    Arch Intern Med; 1974 Jun; 133(6):1001-6. PubMed ID: 4597949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.